Related Experiment Videos
The application of gene expression microarray technology to kinetoplastid research
Robert C Duncan1, Poonam Salotra, Neena Goyal
1Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, CBER, FDA, Bethesda, MD, USA. Duncan@CBER.FDA.GOV
Current Molecular Medicine
|September 11, 2004
Summary
Genomic microarrays are discovering new genes in kinetoplastid parasites like Leishmania and Trypanosoma. This research aims to develop novel vaccines and drugs against devastating tropical diseases.
Area of Science:
- Genomics
- Parasitology
- Molecular Biology
Background:
- Kinetoplastida parasites cause severe tropical diseases.
- Current treatments face drug resistance and chronic phase issues.
- Genomic technologies offer new avenues for vaccine and drug development.
Purpose of the Study:
- To apply DNA microarray technology for novel gene discovery in kinetoplastid parasites.
- To identify stage-specific genes and potential drug/vaccine targets.
Main Methods:
- Utilized cDNA and genomic microarrays for Leishmania major.
- Applied genomic microarrays to Leishmania donovani.
- Employed microarrays on Trypanosoma brucei genomic fragments.
Main Results:
- Identified numerous stage-specific genes in Leishmania major.
- Preliminary gene discovery in Leishmania donovani.
- Discovered genes with differential expression between parasite stages in Trypanosoma brucei.
Conclusions:
- DNA microarrays are effective for discovering new genes in kinetoplastid parasites.
- This foundational work will enable future research into drug resistance, disease regulation, and vaccine development.